English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 29, 2026

Recruiters discuss the value of oncology experience for biopharma job seekers
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

Caldera and Vidya secure $478 million in reverse mergers to enter public markets
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

Incyte discontinues early-stage JAK inhibitor to focus on advanced cancer therapies
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

Researchers develop CapuchinAI system for automated cognitive testing of wild primates
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

FDA releases briefing documents ahead of Capricor and Replimune advisory meetings
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

HOPE initiative launches in Oklahoma to promote lung cancer screening and tobacco cessation
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

Low-fat diet linked to lower glycation compound intake in postmenopausal women, study finds
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

Study finds healthcare preferences in older adults vary by age, sex, and education

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes